For 29-year-old business owner Stephen Tucker, whether he can return to work in Sydney today means choosing to receive the AstraZeneca vaccine over Pfizer.
"Somehow, one of the richest countries in the world and the home to CSL, one of the largest global biotechnology manufacturers, looks set to be slower than developing backwaters in vaccinating their population."
The federal government's announcement of supply agreements with Novavax and Pfizer potentially increases the pool of COVID-19 vaccines Australians will be able to access.
A recent decision by the Fair Work Commission could have widespread ramifications on how sick leave for shift workers is calculated and lead to millions of dollars in backpay